Screener
Xeris Biopharma Holdings, Inc. XERS Free cash flow
Discontinued — last reported Q4 '21
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-K, filed March 6, 2024. Open the filing →
- Filed
- Mar 6, 2024
- Fiscal year
- FY2023
- Accession
- 0001867096-24-000031
FAQ
- What is Xeris Biopharma Holdings, Inc.'s free cash flow?
- Xeris Biopharma Holdings, Inc. (XERS) reported free cash flow of -$29.08M in Q4 2021.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Xeris Biopharma Holdings, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude